
Carl J. Arbes
Examiner (ID: 12863, Phone: (571)272-4563 , Office: P/3729 )
| Most Active Art Unit | 3729 |
| Art Unit(s) | 3726, 2103, 3727, 3206, 3201, 3202, 3729, 2899, 2831 |
| Total Applications | 4677 |
| Issued Applications | 4193 |
| Pending Applications | 65 |
| Abandoned Applications | 435 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19792121
[patent_doc_number] => 12233044
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-02-25
[patent_title] => Cannabidiol and chitosan compositions and methods of using the same
[patent_app_type] => utility
[patent_app_number] => 17/982745
[patent_app_country] => US
[patent_app_date] => 2022-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 11
[patent_no_of_words] => 14610
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17982745
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/982745 | Cannabidiol and chitosan compositions and methods of using the same | Nov 7, 2022 | Issued |
Array
(
[id] => 18886361
[patent_doc_number] => 11865117
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-09
[patent_title] => Pharmaceutical compositions comprising meloxicam
[patent_app_type] => utility
[patent_app_number] => 18/051656
[patent_app_country] => US
[patent_app_date] => 2022-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 33
[patent_no_of_words] => 23915
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18051656
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/051656 | Pharmaceutical compositions comprising meloxicam | Oct 31, 2022 | Issued |
Array
(
[id] => 18449497
[patent_doc_number] => 20230190773
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => INHIBITION OF SLC TRANSPORTER ACTIVITY OR EXPRESSION TO ATTENUATE ANTHRACYCLINE-INDUCED CARDIOTOXICITY
[patent_app_type] => utility
[patent_app_number] => 18/051386
[patent_app_country] => US
[patent_app_date] => 2022-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28169
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18051386
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/051386 | Inhibition of SLC transporter activity or expression to attenuate anthracycline-induced cardiotoxicity | Oct 30, 2022 | Issued |
Array
(
[id] => 18285049
[patent_doc_number] => 20230100521
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => COMPOSITIONS CONTAINING INOSITOL-STABILIZED ARGININE SILICATE COMPLEXES AND INOSITOL FOR IMPROVING COGNITIVE FUNCTION IN VIDEO GAMERS
[patent_app_type] => utility
[patent_app_number] => 17/959661
[patent_app_country] => US
[patent_app_date] => 2022-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4802
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17959661
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/959661 | COMPOSITIONS CONTAINING INOSITOL-STABILIZED ARGININE SILICATE COMPLEXES AND INOSITOL FOR IMPROVING COGNITIVE FUNCTION IN VIDEO GAMERS | Oct 3, 2022 | Abandoned |
Array
(
[id] => 19401393
[patent_doc_number] => 20240284904
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-29
[patent_title] => Antibacterial Composition
[patent_app_type] => utility
[patent_app_number] => 18/563694
[patent_app_country] => US
[patent_app_date] => 2022-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4575
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 360
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18563694
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/563694 | Antibacterial Composition | Sep 27, 2022 | Pending |
Array
(
[id] => 20076225
[patent_doc_number] => 12350259
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-07-08
[patent_title] => Methods of treating migraine
[patent_app_type] => utility
[patent_app_number] => 17/953536
[patent_app_country] => US
[patent_app_date] => 2022-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 11713
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17953536
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/953536 | Methods of treating migraine | Sep 26, 2022 | Issued |
Array
(
[id] => 18525463
[patent_doc_number] => 11712441
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-01
[patent_title] => Pharmaceutical compositions comprising meloxicam
[patent_app_type] => utility
[patent_app_number] => 17/930272
[patent_app_country] => US
[patent_app_date] => 2022-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 35
[patent_no_of_words] => 24933
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17930272
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/930272 | Pharmaceutical compositions comprising meloxicam | Sep 6, 2022 | Issued |
Array
(
[id] => 18208081
[patent_doc_number] => 20230054339
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-23
[patent_title] => COMPOSITIONS AND METHODS OF MODULATING S-NITROSYLATION
[patent_app_type] => utility
[patent_app_number] => 17/899121
[patent_app_country] => US
[patent_app_date] => 2022-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16230
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17899121
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/899121 | Compositions and methods of modulating S-nitrosylation | Aug 29, 2022 | Issued |
Array
(
[id] => 18107860
[patent_doc_number] => 20230000740
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-05
[patent_title] => ALCOHOL BASED SANITIZER WITH IMPROVED DERMAL COMPATIBILITY AND FEEL
[patent_app_type] => utility
[patent_app_number] => 17/822039
[patent_app_country] => US
[patent_app_date] => 2022-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9889
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17822039
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/822039 | Alcohol based sanitizer with improved dermal compatibility and feel | Aug 23, 2022 | Issued |
Array
(
[id] => 18075821
[patent_doc_number] => 20220401433
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-22
[patent_title] => Method of Treating Renal Cell Carcinoma Using N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, (2S)-hydroxybutanedioate
[patent_app_type] => utility
[patent_app_number] => 17/888356
[patent_app_country] => US
[patent_app_date] => 2022-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39508
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17888356
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/888356 | Method of Treating Renal Cell Carcinoma Using N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, (2S)-hydroxybutanedioate | Aug 14, 2022 | Abandoned |
Array
(
[id] => 18619099
[patent_doc_number] => 11752121
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-12
[patent_title] => SmartCore compositions and methods
[patent_app_type] => utility
[patent_app_number] => 17/886354
[patent_app_country] => US
[patent_app_date] => 2022-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 4363
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17886354
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/886354 | SmartCore compositions and methods | Aug 10, 2022 | Issued |
Array
(
[id] => 18018939
[patent_doc_number] => 20220370438
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-24
[patent_title] => METHOD FOR INDUCING A SUSTAINED IMMUNE RESPONSE
[patent_app_type] => utility
[patent_app_number] => 17/881875
[patent_app_country] => US
[patent_app_date] => 2022-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27389
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17881875
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/881875 | METHOD FOR INDUCING A SUSTAINED IMMUNE RESPONSE | Aug 4, 2022 | Abandoned |
Array
(
[id] => 18034488
[patent_doc_number] => 20220378703
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-01
[patent_title] => IMMEDIATE RELEASE FORMULATIONS OF CANNABINOIDS
[patent_app_type] => utility
[patent_app_number] => 17/880420
[patent_app_country] => US
[patent_app_date] => 2022-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7536
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17880420
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/880420 | Immediate release formulations of cannabinoids | Aug 2, 2022 | Issued |
Array
(
[id] => 18337464
[patent_doc_number] => 20230129413
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-27
[patent_title] => Levodopa and Carbidopa Intestinal Gel and Methods of Use
[patent_app_type] => utility
[patent_app_number] => 17/817191
[patent_app_country] => US
[patent_app_date] => 2022-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17227
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 156
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17817191
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/817191 | Levodopa and Carbidopa Intestinal Gel and Methods of Use | Aug 2, 2022 | Abandoned |
Array
(
[id] => 18716468
[patent_doc_number] => 11793789
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-24
[patent_title] => Treatment of ophthalmological conditions using buffer-free ophthalmological compositions of ketorolac and phenylephrine
[patent_app_type] => utility
[patent_app_number] => 17/871924
[patent_app_country] => US
[patent_app_date] => 2022-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49288
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 147
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17871924
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/871924 | Treatment of ophthalmological conditions using buffer-free ophthalmological compositions of ketorolac and phenylephrine | Jul 22, 2022 | Issued |
Array
(
[id] => 18491505
[patent_doc_number] => 11696910
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-07-11
[patent_title] => Buffer-free, stable ophthalmological compositions of ketorolac and phenylephrine and applications thereof
[patent_app_type] => utility
[patent_app_number] => 17/871920
[patent_app_country] => US
[patent_app_date] => 2022-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49272
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 274
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17871920
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/871920 | Buffer-free, stable ophthalmological compositions of ketorolac and phenylephrine and applications thereof | Jul 22, 2022 | Issued |
Array
(
[id] => 18162623
[patent_doc_number] => 20230029216
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-26
[patent_title] => METHOD FOR TREATING SICKLE CELL DISEASE USING QUERCETIN-CONTAINING COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/865609
[patent_app_country] => US
[patent_app_date] => 2022-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9135
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17865609
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/865609 | Method for treating sickle cell disease using quercetin-containing compositions | Jul 14, 2022 | Issued |
Array
(
[id] => 18148589
[patent_doc_number] => 20230022446
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-26
[patent_title] => Anti-Androgens For The Treatment Of Non-Metastatic Castration-Resistant Prostate Cancer
[patent_app_type] => utility
[patent_app_number] => 17/863967
[patent_app_country] => US
[patent_app_date] => 2022-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20132
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17863967
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/863967 | Anti-Androgens For The Treatment Of Non-Metastatic Castration-Resistant Prostate Cancer | Jul 12, 2022 | Abandoned |
Array
(
[id] => 18842590
[patent_doc_number] => 20230404994
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-21
[patent_title] => MARKERS OF TISSUE AGING AND USES THEREFOR
[patent_app_type] => utility
[patent_app_number] => 17/860246
[patent_app_country] => US
[patent_app_date] => 2022-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12021
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17860246
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/860246 | MARKERS OF TISSUE AGING AND USES THEREFOR | Jul 7, 2022 | Abandoned |
Array
(
[id] => 19903045
[patent_doc_number] => 12280029
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-04-22
[patent_title] => Methods of treatment of inflammation related conditions using pluripotent anti-inflammatory and metabolic modulators
[patent_app_type] => utility
[patent_app_number] => 17/833315
[patent_app_country] => US
[patent_app_date] => 2022-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 2135
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17833315
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/833315 | Methods of treatment of inflammation related conditions using pluripotent anti-inflammatory and metabolic modulators | Jun 5, 2022 | Issued |